Sycamore Labs | $65,000,000 | (Mar 31, 2026)
Deccan AI | $25,000,000 | (Mar 31, 2026)
Stedi | $50,000,000 | (Mar 31, 2026)
Perceive Biotherapeutics, Inc.
United States
- South San Francisco, California
- 20/02/2025
- Series A
- $15,000,000
A start-up developing novel ophthalmic therapeutics to treat major unmet needs for patients.
PLEASE NOTE: Be aware of fake job listings on popular job posting websites that attempt to collect personal information from job applicants. Please note that Perceive Bio will only collect personal information using a legitimate company email domain, and will never offer payment or any financial transaction over text or email. Always verify that emails are directly from the company: from an @perceivebio.com email address. We will NOT ask you to purchase home office equipment or transfer other money as part of a hiring process. We will NOT contact you over Signal or WhatsApp as part of our recruiting process. We WILL ALWAYS meet with you in person (not over an electronic communication only) before hiring you.
- Industry Pharmaceutical Manufacturing
- Website www.perceivebio.com
- LinkedIn https://www.linkedin.com/company/perceive-bio/
OpenBox AI | $5,000,000 | (Mar 31, 2026)
Qodo | $70,000,000 | (Mar 31, 2026)
Starcloud | $170,000,000 | (Mar 31, 2026)
Valinor(1) | $25,000,000 | (Mar 31, 2026)
Mars Men | $27,500,000 | (Mar 31, 2026)
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)